The Overdiagnosis Trap: Why Common Prostate Screenings Often Lead to Unnecessary Harm

What if one of the greatest risks in prostate cancer isn't the cancer itself, but the cascade of testing and treatment that follows an elevated PSA? In this episode, Dr. Stephen Petteruti examines one of the most controversial topics in men's health: overdiagnosis and overtreatment of prostate cancer. He explains how a single PSA result can set off a chain of events that often includes prostate biopsy, Gleason grading, surgery, radiation, or hormone therapy, even when many prostate cancers may never become life-threatening. You'll learn why PSA should be viewed as a trend rather than a diagnosis, how arbitrary PSA cutoffs have influenced medical decision-making for decades, and why inflammation, benign prostatic hyperplasia (BPH), prostatitis, prostate size, and normal biological variation can all affect PSA levels. Dr. Petteruti also discusses the limitations of prostate biopsy, the challenges of interpreting Gleason scores, and why identifying cancer does not always mean immediate treatment is the best option. Instead, he explains the role of sequential PSA monitoring, multiparametric MRI, metabolic health, and individualized decision-making in helping men better understand their risk before making life-changing decisions. If you've recently been diagnosed with prostate cancer, have an elevated PSA, are considering a prostate biopsy, or simply want to better understand your options, this episode offers a different perspective on prostate screening and prostate cancer management. The goal isn't to ignore prostate cancer. The goal is to avoid unnecessary harm while making informed decisions that protect both longevity and quality of life. In This Episode 00:00 Introduction 03:59 Fear and financial incentives in prostate care 06:51 The risks and limitations of prostate biopsy 09:50 PSA cutoffs and false-positive concerns 12:50 Gleason scores and overtreatment 15:33 Why no single test predicts outcomes 18:38 Incentives that influence medical decision-making 21:34 A different approach to prostate health 23:13 Closing thoughts Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms. Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care. 📚 Resources Dr. Petteruti Men's Vitality Group https://www.intellectualmedicine.com/... Fight Cancer Like a Man https://www.amazon.com/Fight-Cancer-L... Dr. Petteruti's Newsletter https://drstephenpetteruti.substack.c... Podcast Show Notes https://www.intellectualmedicine.com/... 🌐 Learn More Dr. Stephen Petteruti https://www.drstephenpetteruti.com/ Intellectual Medicine https://www.intellectualmedicine.com/ 📱 Connect with Dr. Petteruti Instagram   / dr.stephenpetteruti   Facebook   / dr.stephenpetteruti   🎧 Listen to the Podcast Apple Podcasts https://podcasts.apple.com/us/podcast... Spotify https://open.spotify.com/show/3om1BQG... #Overdiagnosis #ProstateHealth #MensVitality #ActiveSurveillance Disclaimer: The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.